Coronary myocardial bridge imaging by stress-echocardiography and coronary adipose tissue attenuation on computed tomography angiography-Reference-Cited by-同舟云学术

Coronary myocardial bridge imaging by stress-echocardiography and coronary adipose tissue attenuation on computed tomography angiography

Published:2024-02-29 Issue:1 Volume:2 Page:31-39
ISSN:
Container-title:Exploration of Cardiology
language:
Short-container-title:Explor Cardiol

Author:

Tuttolomondo Domenico¹^ORCID,Dey Damini²^ORCID,Slomka Piotr J³^ORCID,Pizzi Carmine⁴^ORCID,Bergamaschi Luca⁴^ORCID,Gaibazzi Nicola¹^ORCID

Affiliation:

1. Cardiology Unit, University Hospital of Parma, 43126 Parma, Italy

2. Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA

3. Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA

4. Unit of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine-DlMES, IRCCS AOU SOrsola-University of Bologna, 40126 Bologna, Italy

Abstract

Myocardial bridging is a congenital defect characterized by the course of a segment of the coronary arteries within the heart muscle most frequently affecting the left anterior descending coronary artery (LAD). Patients with myocardial bridging may present with episodes of exertional anginal chest pain. The gold standard for non-invasive diagnosis of myocardial bridge is coronary computed tomography angiography (CCTA), which allows anatomical characterization. Coronary flow velocity reserve (CFVR) of the LAD on stress echocardiography (SE) can play an important role in the diagnosis of myocardial bridging of the LAD; a relationship between CVFR-LAD and coronary inflammation by estimating the attenuation of peri-coronary adipose tissue at CCTA has been demonstrated in patients without obstructive ischaemic heart disease. Therefore, coronary inflammation localized to the LAD has been assessed in patients diagnosed with myocardial bridging of the LAD and previous SE with CFVR-LAD in a case series.

Publisher

Open Exploration Publishing

Reference27 articles.

1. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes: the task force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2020;41:407–77.

2. Gaibazzi N, Tuttolomondo D, Guaricci AI, De Marco F, Pontone G. Stress-echocardiography or coronary computed tomography in suspected chronic coronary syndrome after the 2019 European Guidelines? A practical guide. J Cardiovasc Med (Hagerstown). 2022;23:12–21.

3. Bergamaschi L, Pavon AG, Angeli F, Tuttolomondo D, Belmonte M, Armillotta M, et al. The role of non-invasive multimodality imaging in chronic coronary syndrome: anatomical and functional pathways. Diagnostics (Basel). 2023;13:2083.

4. Magnani G, Denegri A, Gurgoglione FL, Barocelli F, Indrigo E, Catellani D, et al. Dual antiplatelet therapy or antiplatelet plus anticoagulant therapy in patients with peripheral and chronic coronary artery disease: an updated review. J Clin Med. 2023;12:5284.

5. Gaibazzi N, Foà A, Bergamaschi L, Tuttolomondo D, Pizzi C. The war for the best therapy in coronary artery disease is far from being won. J Am Coll Cardiol. 2022;80:e167.